Pangea Biomed
Pan-cancer Therapy Response Predictor
Active
Seed
Startup
Tel Aviv-Yafo
Founded 2018-03
Pangea Biomed is the developer of ENLIGHT, an advanced pan-cancer, pan-therapy response predictor. By combining machine learning, artificial intelligence, and deep RNA analysis, the company is mapping tumor molecular signatures to dynamically and adaptively personalize cancer care. Pangea's unsupervised machine-learning approach makes ENLIGHT scalable and e…
SectorHealth Tech & Life Sciences
StageSeed
Total raised$12.0M
Employees17
Founded2018-03
HQTel Aviv-Yafo
Crunchbasepangea-biomed
Confidence91
Sectors
Health Tech & Life SciencesDigital HealthcareMedical Decision SupportPharma & Medical BiotechnologyDrugs Discovery & Development
Technology
Artificial IntelligenceMachine Learning
Target customers
Healthcare & Life SciencesHealthcareLaboratoriesProvidersLife SciencesPharmaceuticals